U.S. Capital Markets Stock News

Tencent Music Entertainment Group (NYSE:TME) has formed a new joint venture called ONECEAD with CJ ENM and JYP China. The partnership focuses on developing, launching and managing next generation artists for global audiences. ONECEAD is intended to combine music production, artist management and content distribution capabilities across China, Korea and international markets. For investors watching NYSE:TME, this move comes with the stock at $16.4 and a 1 year return of 38.2%. Over 3 years,...

If you are wondering whether ADMA Biologics at US$17.52 still offers value or has already run too far, this breakdown will help you put the current share price in context. The stock has had mixed returns, with a 7.3% gain over the last week, a 2.8% decline over the last month, a 2.0% decline year to date, a 3.9% return over the past year, and a very large return over three and five years. Recent coverage of ADMA Biologics has focused on its share price performance over different time frames,...

Coty recently announced a collaboration with OpenAI to roll out ChatGPT Enterprise across selected parts of its global organization, aiming to support employees’ daily work, creativity and cross‑functional collaboration with enterprise-grade AI tools. This move positions Coty as an early adopter of advanced AI within the beauty industry, potentially reshaping how it manages innovation, efficiency and internal decision-making. We will now examine how Coty’s adoption of ChatGPT Enterprise...

If you are wondering whether Horace Mann Educators at around US$44.92 still offers value, an important question is how its current price compares with what the business may be worth. The stock has returned 4.7% over the last 7 days, while the 1 year return sits at 21.7% and the 3 year return at 38.6%. A 0.6% decline year to date may suggest that expectations and risk perceptions are changing. Recent coverage has focused on Horace Mann Educators as an insurer serving the education community,...

Key Insights The considerable ownership by private companies in GDEV indicates that they collectively have a greater...

Key Insights The considerable ownership by individual investors in NovaBridge Biosciences indicates that they...

To the annoyance of some shareholders, Nocera, Inc. ( NASDAQ:NCRA ) shares are down a considerable 37% in the last...

Some AZZ Inc. ( NYSE:AZZ ) shareholders may be a little concerned to see that the President, Thomas Ferguson, recently...

One thing we could say about the analysts on Aquestive Therapeutics, Inc. ( NASDAQ:AQST ) - they aren't optimistic...

Seadrill (NYSE:SDRL) is being discussed as a potential acquisition target, with management indicating openness to a sale at a premium. The company has announced several significant contract wins and extensions for its ultra deepwater fleet. These new contracts add to Seadrill's revenue backlog and provide increased visibility on future operations. The combination of M&A interest and fresh contract activity is drawing attention to Seadrill's position in the offshore drilling...

If you are wondering whether Simon Property Group's current share price reflects its true value, you are not alone. This article will help you connect the recent share performance with what the fundamentals may be pointing to. At a last close of US$189.42, the stock has returns of 2.6% over the past 7 days, 3.0% over the past 30 days, 3.0% year to date, 14.8% over 1 year and 141.0% over 5 years, which naturally raises questions about how much of this is already priced in. Recent attention on...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Why Global Payments Is Back In Focus Recent coverage around Global Payments (GPN) has focused on its growth metrics, cash flow characteristics, and earnings estimate trends, connecting those fundamentals to its behind the scenes role in digital payment infrastructure. See our latest analysis for Global Payments. Despite recent attention on its growth profile and role in digital payments, Global Payments' share price has come under pressure, with a 1 day share price return of a 6.64% decline...

Sagimet Biosciences recently reported that Ascletis Pharma’s Phase 3 trial of ASC40 (Denifanstat) for acne met all primary and secondary endpoints and was well-tolerated, with no serious adverse events observed. The results highlight fatty acid synthase (FASN) inhibition as a potentially new way to treat acne, with findings slated for presentation at upcoming medical congresses and in scientific publications. Next, we’ll examine how Denifanstat’s Phase 3 success in acne may influence Sagimet...

BTIG recently highlighted Dynex Capital (DX) after President Trump directed government sponsored enterprises to purchase up to US$200b in mortgage backed securities. This has focused attention on how tighter agency MBS spreads could affect the REIT. See our latest analysis for Dynex Capital. That policy news has arrived alongside a busy few weeks for Dynex Capital, with fourth quarter and full year 2025 results and a new Chief Operating Officer appointment helping keep the stock in focus. At...

This article walks through key signals you can use to assess whether Under Armour at around US$6.24 might be a bargain or a value trap. The stock is up 18.0% over the last month and 18.0% year to date, while the 1-year return of negative 24.4% and 3- and 5-year returns of negative 48.9% and negative 69.9% highlight a much tougher longer-term picture. Recent attention on Under Armour has focused on how the brand fits into an increasingly competitive athletic apparel market and what that could...

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

Why Jones Lang LaSalle (JLL) is on investors’ radar today Jones Lang LaSalle (JLL) has attracted fresh attention after recent price moves, with the stock showing mixed returns over the past week, month and past 3 months, prompting investors to reassess its real estate exposure. See our latest analysis for Jones Lang LaSalle. The recent 1 day share price decline of 6.5% and 7 day share price return of 7.1% come after a stronger 90 day share price return of 15%. The 1 year total shareholder...

If you are wondering whether Wintrust Financial's recent share price leaves much upside on the table, it starts with understanding what the current market price is really implying about the bank's long term prospects. The stock last closed at US$156.04, with returns of 7.3% over the past week, 9.4% over the past month, 9.4% year to date and 22.8% over the past year. The 3 year and 5 year returns sit at 72.2% and 149.7% respectively. These returns have helped put Wintrust Financial on the...

If you are wondering whether U.S. Bancorp's share price still offers value after a solid run, this article walks through what the current market price could be implying about the business. With the stock last closing at US$58.69, U.S. Bancorp has recorded returns of 3.8% over 7 days, 8.8% over 30 days, 8.8% year to date, 29.1% over 1 year, 36.3% over 3 years, and 52.7% over 5 years. Recent coverage of large U.S. banks has focused on how they are positioned under current interest rate...

Expanded portfolio roadmap tied to AI-driven connectivity needs Astera Labs (ALAB) is expanding its portfolio roadmap to cover increased radix, platform-specific protocols, in-network computing, Hypercast technology, and optical connectivity, all shaped by feedback from hyperscalers. See our latest analysis for Astera Labs. Astera Labs’ latest connectivity roadmap lands after a mixed stretch for the stock, with a 1-day share price return of 3.99% to US$158.52 contrasting with weaker recent...

If you have been watching AES and wondering whether the recent share price puts it on sale or not, this article will walk through what the current valuation actually looks like. The stock last closed at US$16.09, with returns of 7.8% over the past week, 8.6% over the past month and year to date, while the 1 year return sits at 60.3% compared to a 30.1% decline over 3 years and a 30.3% decline over 5 years. Recent headlines around AES have focused on its role as a major US utilities player...

Universal Health Services (UHS) is back in focus after investors responded to easing staffing pressures, firm behavioral health demand, and recent quarterly results that came in ahead of expectations, supported by resilient margins and steady acute care volumes. See our latest analysis for Universal Health Services. The recent easing in staffing pressures and stronger behavioral health trends sit against a mixed share price picture, with a 2.5% 1 day share price return and 2.1% 7 day share...

Abercrombie & Fitch (NYSE:ANF) has introduced a new sportswear collaboration with NFL teams tied to the upcoming Super Bowl. The collection focuses on exclusive game day apparel designed to capture Super Bowl related merchandise demand. The launch aims to increase brand visibility through sports partnerships and reach consumers beyond Abercrombie & Fitch's traditional retail focus. Abercrombie & Fitch enters this NFL collaboration with shares at $100.31 and a mixed return profile. The stock...